Days Inventory is also known as Days Sales of Inventory (DSI). Sonoma Pharmaceuticals's Average Total Inventories for the
three
months ended in Dec. 2023 was $2.73 Mil. Sonoma Pharmaceuticals's Cost of Goods Sold for the
three
months ended in Dec. 2023 was $1.68 Mil.
Hence, Sonoma Pharmaceuticals's Days Inventory for the
three
months ended in Dec. 2023 was 148.68.
The historical rank and industry rank for Sonoma Pharmaceuticals's Days Inventory or its related term are showing as below:
SNOA'
s Days Inventory Range Over the Past 10 Years
Min: 69.21 Med: 98.3 Max: 130.27
Current: 130.27
During the past 13 years, Sonoma Pharmaceuticals's highest Days Inventory was 130.27. The lowest was 69.21. And the median was 98.30.
SNOA's Days Inventory is ranked better than 61.54% of 975
companies
in the Drug Manufacturers industry
Industry Median: 157.96
vs SNOA: 130.27
Sonoma Pharmaceuticals's Days Inventory
increased
from Dec. 2022 (126.83) to Dec. 2023 (148.68).
It might indicate that Sonoma Pharmaceuticals's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sonoma Pharmaceuticals's Inventory Turnover for the
three
months ended in Dec. 2023 was 0.61.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sonoma Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Dec. 2023 was 0.87.
Sonoma Pharmaceuticals Days Inventory Historical Data
The historical data trend for Sonoma Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Sonoma Pharmaceuticals's Days Inventory
For the Drug Manufacturers - Specialty & Generic subindustry, Sonoma Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sonoma Pharmaceuticals's Days Inventory Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sonoma Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Sonoma Pharmaceuticals's Days Inventory falls into.
Sonoma Pharmaceuticals Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Sonoma Pharmaceuticals's Days Inventory for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sonoma Pharmaceuticals (NAS:SNOA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Sonoma Pharmaceuticals's Inventory Turnover for the
three
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sonoma Pharmaceuticals's Inventory to Revenue for the
three
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Sonoma Pharmaceuticals Days Inventory Related Terms
Thank you for viewing the detailed overview of Sonoma Pharmaceuticals's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Sonoma Pharmaceuticals (Sonoma Pharmaceuticals) Business Description
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, and other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SNOA has been successfully added to your 